Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed attachment file name title question first answered answering member label
tabling member	label

Search

887308

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dental Services
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what was the total value of undelivered contracted units of dental activity in NHS dental contracts in England in each year from 2012–13 to 2016–17.
tabling member printed	Baroness Eaton
uin	HL7105
answer	answer is ministerial correction date of answer 03/05/2018 answer text <p>This information is not held centrally.</p> answering member printed Lord O'Shaughnessy question first answered 03/05/2018 10:52:03 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	4184 label Biography information for Baroness Eaton

887313

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Records: Data Protection
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government from when a national data opt-out expressed directly to NHS Digital will apply to data shared for secondary uses by a GP practice and be visible to GP practices.
tabling member printed	Lord Hunt of Kings Heath
uin	HL7110
answer	answer is ministerial correction date of answer 03/05/2018 answer text <p>In line with the implementation plan set out in the Government response to the National Data Guardian’s Review of Data Security, Consent and Opt-Outs, <em>Your Data: Better Security, Better Choice, Better Care</em>, general practitioner (GP) practices will be required to apply national data opt-outs, expressed to NHS Digital, by March 2020. By this date national data opt-outs must be applied by all health and care organisations in line with the national data opt-out policy when confidential patient information is being shared for purposes beyond the patient’s individual care (also referred to as secondary uses). NHS Digital has commissioned the GP system suppliers to develop solutions for their GP systems which will enable GP practices to uphold national data opt-outs. We will publish further details as these solutions become available.</p> answering member printed Lord O'Shaughnessy question first answered 03/05/2018 10:58:31 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

887314

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Records: Data Protection
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government which stakeholders were asked, prior to 16 April, to comment on the content of a draft of any letter to patients for the national data opt-out programme.
tabling member printed	Lord Hunt of Kings Heath
uin	HL7111
answer	answer is ministerial correction date of answer 03/05/2018 answer text <p>Prior to 16 April 2018, the National Data Opt-out Programme has asked a number of stakeholders to comment on a draft letter that in its final form will be issued to all patients that have a type 2 opt-out recorded on their electronic patient record held at their general practitioner practice. The stakeholders asked to comment were:</p><p> </p><p>- The National Data Guardian Panel;</p><p>- The Information Commissioner’s Office;</p><p>- British Heart Foundation and Cancer Research UK Patient Panel;</p><p>- Plain English Campaign;</p><p>- The National Data Opt-out Advisory Group; and</p><p>- The National Data Opt-out Editorial Board.</p><p> </p><p>The letter was shared with other organisations after 16 April 2018.</p><p> </p> answering member printed Lord O'Shaughnessy question first answered 03/05/2018 10:56:34 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

887315

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the impact of the UK not remaining part of the European Medicines Agency after Brexit on (1) the safety of new drugs, and (2) the safety of drugs targeted at rare diseases.
tabling member printed	Baroness Masham of Ilton
uin	HL7112
answer	answer is ministerial correction date of answer 03/05/2018 answer text <p>From 30 March 2019, the United Kingdom will no longer be a member of the European Union. However, under the terms of the implementation period agreement, regulatory standards and market access for all medicines will continue on current terms.</p><p>In regard to the future relationship, the Prime Minister's Mansion House speech outlined that we will also explore the terms on which the UK could remain part of the European Medicines Agency. While it would not be appropriate to pre-judge the outcome of the negotiations, we will discuss with the EU and Member States how best to continue cooperation in medicines regulation.</p><p>Our aim is to ensure that, whatever outcome is achieved, patients in the UK and across the EU continue to be able to access the best and most innovative medicines including those medicines targeted at rare diseases, and be assured that their safety is protected through the strongest regulatory framework and sharing of data.</p> answering member printed Lord O'Shaughnessy question first answered 03/05/2018 10:57:42 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1850 label Biography information for Baroness Masham of Ilton

887328

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hepatitis
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what progress the Operational Delivery Networks have made against the Hepatitis C 2020 Impact Targets set out in the World Health Organisation’s Global health sector strategy on viral hepatitis 2016–21 and Appendix 1 of the Hepatitis C in England 2017 report.
tabling member printed	Baroness Randerson
uin	HL7125
answer	answer is ministerial correction date of answer 03/05/2018 answer text <p>The 2020 impact targets set out in the World Health Organization’s (WHO) Global Health Sector Strategy on viral hepatitis 2016- 1 and Appendix 1 of the Hepatitis C in England 2017 report focus on reducing the number of new cases of chronic viral hepatitis C infection and mortality rates.</p><p> </p><p>A summary of progress towards achieving the WHO elimination goal was published in 2017 in Public Health England’s (PHE) report <em>Hepatitis C in the UK 2017 report: Working to eliminate hepatitis C as a major public health threat</em>. Further progress for England only was recently published by PHE in <em>Hepatitis C in England 2018 report: Working to eliminate heptatis C as a major public health threat</em>. Copies of these reports are attached.</p><p> </p><p>These progress reports have shown that the United Kingdom is on target to meet the WHO interim goal of reducing hepatitis C mortality by 10% by 2020. Better access to improved treatment and prioritising patients with highest unmet clinical need has led to the first fall in deaths from severe hepatitis C related liver disease in a decade.</p><p> </p><p>Assessing the impact Operational Delivery Networks directly have on the incidence of infection is a challenge as this is difficult to measure. Most proxy indicators of incidence suggest that that numbers of new hepatitis C cases have remained relatively stable over recent years.</p><p>Successful delivery of treatments, alongside the contributions of other public health services such as needle exchange and opioid substitution services, will have an effect on incidence. Ongoing monitoring of trends of identification of new cases, and of overall annual prevalence, will continue to be important.</p><p> </p><p> </p> answering member printed Lord O'Shaughnessy attachment 1 file name HCV_in_the_uk_report_2017.pdf title Hepatitis C in the UK 2017 Report 2 file name HCV_in_England_2018.pdf title Hepatitis C in England 2018 Report question first answered 03/05/2018 10:50:43 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	4230 label Biography information for Baroness Randerson

887331

registered interest
date	19/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dental Services: Children
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government how many children who have had a general anaesthetic for dental extraction had been (1) registered with, and (2) treated by, a dentist in the previous two years.
tabling member printed	Lord Storey
uin	HL7128
answer	answer is ministerial correction date of answer 03/05/2018 answer text <p>No data is held centrally on the number of children who have had a general anaesthetic administered for dental extractions that had been registered with and treated by a dentist in the previous two years.</p> answering member printed Lord O'Shaughnessy question first answered 03/05/2018 10:52:24 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	4238 label Biography information for Lord Storey